Xia, S., Liu, M., Wang, C., Xu, W., Lan, Q., Feng, S., . . . Lu, L. (2020). Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res.
Citação norma ChicagoXia, Shuai, et al. "Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection By a Highly Potent Pan-coronavirus Fusion Inhibitor Targeting Its Spike Protein That Harbors a High Capacity to Mediate Membrane Fusion." Cell Res 2020.
Citação norma MLAXia, Shuai, et al. "Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection By a Highly Potent Pan-coronavirus Fusion Inhibitor Targeting Its Spike Protein That Harbors a High Capacity to Mediate Membrane Fusion." Cell Res 2020.